image
Cytokinetics, Incorporated CYTK
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 37.93
-3.93 %
$ 4.52 B
Market Cap
-7.21
P/E
Price Target Average
136.84%
Revenue Forecast Estimate
202.75%
EBIT Estimate
--30.43%
Net Income Estimate
29.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cytokinetics, Incorporated
image
Wall Street analysts predict an average 1-year price target for CYTK of $89.8 , with forecasts ranging from a low of $60 to a high of $120 .
CYTK Lowest Price Target Wall Street Target
60 USD 58.19%
CYTK Average Price Target Wall Street Target
89.8 USD 136.84%
CYTK Highest Price Target Wall Street Target
120 USD 216.37%
Price
Max Price Target
Min Price Target
Average Price Target
1201201101101001009090808070706060505040403030Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart CYTK

image
$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CYTK

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)($1.6b)($1.6b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CYTK

image
$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029